Clinical trials
Phase 2/3 Arthritis, Rheumatoid trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 5 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Unknown status | 10 |
| Recruiting | 3 |
| Terminated | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 5 |
| Ain Shams University | 3 |
| Centers for Disease Control and Prevention | 3 |
| Cui xuejun | 3 |
| Abbott | 2 |
| AB Science | 1 |
| AbbVie | 1 |
| Alexandria University | 1 |
| Bellus Health Inc. - a GSK company | 1 |
| Bristol-Myers Squibb | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis, Rheumatoid | 41 |
| Osteoarthritis | 5 |
| Arthritis | 4 |
| Pain | 2 |
| Scleroderma, Diffuse | 2 |
| Amyloidosis | 1 |
| Autoimmune Diseases | 1 |
| Connective Tissue Diseases | 1 |
| Dermatomyositis | 1 |
| Disease | 1 |
Trials
Showing 76 to 41 of 41. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.